Search

Sanofi

Deschisă

46.89 -1.22

Rezumat

Modificarea prețului

24h

Curent

Minim

46.84

Maxim

47.59

Indicatori cheie

By Trading Economics

Venit

-1.3B

343M

Vânzări

1.1B

12B

P/E

Medie Sector

22.662

51.78

EPS

2.04

Marjă de profit

2.789

Angajați

74,846

EBITDA

1.3B

4B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+25.34% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

4.3B

109B

Deschiderea anterioară

48.11

Închiderea anterioară

46.89

Sanofi Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 nov. 2026, 23:56 UTC

KBR Inc shares are down significantly in after-market trading, falling to their lowest point of the day.

4 nov. 2026, 23:56 UTC

News
Social Media

Trimble Inc appoints Matthew C. Brown, former CFO of Tenable Holdings, to its Board of Directors in after-market trading.

4 nov. 2026, 23:56 UTC

Correlated Moves

D.R. Horton, Inc. shares traded modestly lower in after-market hours, while Amcor PLC's sharp decline followed disappointing Q1 results and lowered EPS guidance.

4 nov. 2026, 23:56 UTC

Hims & Hers Health, Inc. is trading modestly higher in after-market hours following an increase during the session.

4 nov. 2026, 23:56 UTC

Correlated Moves

Lattice Semiconductor Corporation shares declined in after-market trading, continuing a downward trend since Wednesday's close and nearing the lower end of their one-month range.

4 nov. 2026, 23:56 UTC

IES Holdings Inc shares rose significantly during after-market hours on Wednesday, recovering from a recent decline and moving higher following the close of regular trading.

4 nov. 2026, 23:56 UTC

Synopsys, Inc. shares are trading modestly higher in after-market hours, recovering from earlier lows after four consecutive daily declines.

4 nov. 2026, 23:52 UTC

News

Uranium Energy Corp. is trading modestly higher in after-market hours following fluctuations since Wednesday's close.

4 nov. 2026, 23:51 UTC

Kontoor Brands, Inc. is trading lower in after-market hours, retreating from a brief uptick and remaining at the lower end of its recent range.

4 nov. 2026, 23:51 UTC

GE HealthCare Technologies Inc. is trading modestly higher in after-market hours, despite a slight decline from earlier session highs.

4 nov. 2026, 23:51 UTC

Mondelez International, Inc. shares have advanced modestly in after-market hours, remaining near the upper end of their one-month range.

4 nov. 2026, 23:51 UTC

Avient Corp is declining in after-market trading, falling to its lowest point of the day.

4 nov. 2026, 23:51 UTC

Lindsay Corporation's shares traded modestly lower during after-market hours on Wednesday, remaining around the midpoint of their one-month trading range.

4 nov. 2026, 23:51 UTC

News

Watts Water Technologies reports Q3 net sales of $728 million, exceeding estimates, with diluted EPS of $4.34 and raises full-year sales growth outlook to 17%-18%.

4 nov. 2026, 23:51 UTC

Twist Bioscience Corporation shares declined during after-market hours on Wednesday, reversing a trend of higher daily closes observed in recent sessions.

4 nov. 2026, 23:51 UTC

Wendy's Co shares are declining in after-market trading, reflecting pronounced losses despite a strong recent performance and seven consecutive sessions of higher closes.

4 nov. 2026, 23:51 UTC

Delta Air Lines, Inc. shares are trading lower in after-market hours, pulling back from earlier gains.

4 nov. 2026, 23:51 UTC

Correlated Moves

Clorox Company shares are modestly lower in after-market trading, following a brief peak earlier in the session.

4 nov. 2026, 23:51 UTC

BlackRock, Inc. shares traded modestly lower in after-market hours, retracing from an early session peak.

4 nov. 2026, 23:51 UTC

Correlated Moves

Vertiv Holdings Co is modestly higher in after-market trading, moving in sympathy with Eaton Corporation PLC following strong third-quarter results.

4 nov. 2026, 23:51 UTC

Redwood Trust, Inc. shares declined during after-market trading on Wednesday, moving notably lower from a modest high shortly after the market closed.

4 nov. 2026, 23:46 UTC

News
Correlated Moves

Chord Energy reports Q3 adjusted EPS of $6.08, exceeding estimates, while revenues of $1.71B missed expectations; raises 2026 adjusted EBITDA guidance to $3.4B.

4 nov. 2026, 23:46 UTC

Martin Marietta Materials, Inc. is trading modestly higher in after-market hours, reaching its highest level since Wednesday's close and above its 20-day moving average.

4 nov. 2026, 23:46 UTC

ZIM Integrated Shipping Services Ltd is trading lower in after-market hours, continuing its downward trend from Wednesday's close and positioned 3.49% below its 20-day moving average.

4 nov. 2026, 23:46 UTC

News

UBS maintains Neutral rating on Coca-Cola Europacific Partners PLC and raises price target to $115 in a report published after the market closed.

4 nov. 2026, 23:46 UTC

The NZD/CAD is trading modestly higher, supported by stronger-than-expected ADP Employment Change data, which reported an increase of 86k jobs in October.

4 nov. 2026, 23:46 UTC

GBP/NZD is lower, reflecting a decline since Tuesday's close.S. employment and services data.

4 nov. 2026, 23:46 UTC

Arbor Realty Trust, Inc. traded roughly flat in after-market hours, remaining near the lower end of its one-month range and below its 20-day moving average.

4 nov. 2026, 23:42 UTC

Lincoln Electric Holdings, Inc. is trading lower in after-market hours, reversing an initial gain and marking a fourth consecutive daily decline.

4 nov. 2026, 23:42 UTC

Alector, Inc. is declining sharply in after-market trading, reaching its lowest point of the day after previously showing strength above its 20-day moving average.

Comparație

Modificare preț

Sanofi Așteptări

Obiectiv de preț

By TipRanks

25.34% sus

Prognoză pe 12 luni

Medie 59.5 USD  25.34%

Maxim 62 USD

Minim 57 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruSanofi - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

2 ratings

1

Cumpărare

1

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
help-icon Live chat